Loading…
$1.7B
Market Cap
112.9
P/E
0.83
PEG
6.6%
ROCE
-8.1%
ROE
1.11
D/E
0.8%
OPM
-30.0%
% from 52W High
18
α RS
⚖️ Compare 🔒 Generate Report 🔒 Research Packet 📚 Guides
🌏 Global Investor Returns
Currency-adjusted total returns for ADNT including FX impact
🌏
Click 🌏 Returns tab to load data
📈 Price History
Ratio Health
Excellent
Good
Average
Poor
By Category
📊 Sector Averages
About

Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks in United States.

Key Ratios Snapshot
📈 Growth Pattern
📊 Quick Scorecard
Loading…
⭐ Superinvestors Holding ADNT
View All Superinvestors →
Manager Shares Value % of Fund Period
Jim Simons Renaissance Technologies LLC 294.9K $6.0M 0.01% Mar 2026

SEC Form 13F data. 45-day lag from quarter end.

🔒
Premium Feature
AI-generated 10-section company profile — business model, financials, strengths, risks & management quality
Upgrade to Premium
Already a member? Log in
📐
3-Statement Financial Model
Bear / Base / Bull projections · DCF fair value · Reverse-DCF
Open Model →
🎙 Management Tone Confident Specific → Stable 4 quarters Full tone analysis in Intelligence →
📊 MIXED Adient Q2 2026 revenue $3.9B, adj EBITDA $223M; raises FY guidance modestly
Revenue & Profitability
Q2 2026 revenue was $3.9 billion (up 7% YoY). Adjusted EBITDA was $223 million (down YoY). Adjusted net income was $41 million, or $0.52 per share. Free cash flow was $8 million in Q2 and $23 million year-to-date. FY 2026 guidance raised: revenue ~$14.8 billion, adjusted EBITDA ~$885 million, free cash flow ~$130 million. CapEx unchanged at ~$300 million, cash taxes ~$125 million.
Outlook
Management raised FY 2026 guidance modestly despite a volatile macro environment with geopolitical conflicts, elevated energy/commodity costs, and trade policy uncertainty. Onshoring momentum in the Americas and above-market growth in China (up 10% vs. declining industry) are key positives. Input cost headwinds of $35 million are expected, offset by volume and business performance. EMEA overcapacity continues, but the team is managing through restructuring and commercial actions.
Growth Drivers
Onshoring conquest wins include the Chevrolet Equinox (~200,000 incremental units) and Volkswagen South America (~180,000 units). In China, 70% of new wins are with local OEMs (e.g., XPeng, Leapmotor, Changan). Booked business for FY 2027 is ~$400 million and FY 2028 ~$630 million. The portfolio balances high-volume ICE platforms (e.g., Equinox) with next-gen EV programs (e.g., Rivian R2, Leapmotor D19).
Balance Sheet & CapEx
FY 2026 capital expenditure guidance remains unchanged at ~$300 million, supporting growth initiatives, automation, and innovation. A tuck-in acquisition of a foam production plant in Romulus, Michigan, expands the Americas foam network to 10 plants (30 globally) and strengthens vertical integration. Automation investments in foaming, metals, and trim are aimed at improving efficiency and margins.
Margins
Q2 adjusted EBITDA margin declined 70 basis points, with 60 bps from mix shift (particularly to lower-margin Chinese local OEMs and certain North American platforms). Management expects 100 bps of margin compression in China in FY 2026, but views it as manageable. Underlying business performance remains solid, and H2 is expected to see lower launch costs and accelerating efficiency gains from automation and operational excellence.
Key Risks
Management flags risks from ongoing geopolitical conflicts (Middle East), elevated energy and chemical costs, trade policy uncertainty (USMCA negotiations), and shifting consumer sentiment. Specific near-term headwinds include $25 million from Middle East conflict (chemical/freight costs) and $10 million from the LyondellBasell chemical supply disruption. Customer-driven production inefficiencies and the margin mix shift in China are also noted as manageable risks.
Generated by AI · Q2 2026 results · Not investment advice
🔒
Free Account Required

Create a free Finmagine account to access Finmagine™ Scorecard.

See how this company scores across 5 dimensions — Financial Health, Growth Prospects, Competitive Position, Management Quality, and Valuation — powered by 30+ computed ratios.

Create Free AccountLog In
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Ask AI.

Get 25 expert AI analysis templates — Business KPIs, Comprehensive, Forensic Governance, Peer Comparison, Risk-Reward, Full Research Report, IPO Decoder, Red Flag Detector, and more — ready to paste into ChatGPT, Claude, Gemini, or Perplexity.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Peer Comparison.

Compare this company side-by-side against its sector peers with financial metrics, ratio benchmarking, and relative performance across all key dimensions.

Upgrade to PremiumCreate Free Account
✓ 📞 Earnings Call Transcripts (5 quarters) submit a missing quarter
🔍
🔎 See cross-company document search → ?
📞 Earnings Call Transcripts (5)
Q3 2026 Q3 2026 2026-08-05
Q3 revenue rose 5% year-over-year to $3.9 billion, with adjusted EBITDA flat at $225 million due to external cost pressures. Americas and Asia drove growth, while EMEA improved through restructuring. Fiscal 2026 revenue guidance was raised to ~$15 billion, with solid liquidity and continued focus on automation and capital discipline.
Q2 2026 Q2 2026 2026-05-06
Q2 delivered 7% YoY revenue growth, with strong Americas and Asia performance offset by temporary inefficiencies and input cost headwinds. FY 2026 guidance was raised for revenue, adjusted EBITDA, and free cash flow, supported by new business wins, innovation, and a robust balance sheet.
Q1 2026 Q1 2026 2026-02-04
Q1 delivered strong results with 4% sales growth and higher Adjusted EBITDA, driven by China and FX. Full-year guidance for revenue, EBITDA, and free cash flow was raised, supported by new business wins, onshoring, and innovation.
Q4 2025 Q4 2025 2025-11-05
Delivered strong Q4 and full-year results with $204M free cash flow and 6.1% EBITDA margin, despite volume and tariff headwinds. 2026 outlook anticipates revenue and margin pressure in North America and Europe, offset by growth in China, with continued investment in innovation and automation.
Q3 2025 Q3 2025 2025-08-06
Q3 saw strong adjusted EBITDA growth, margin expansion, and robust free cash flow, driven by operational improvements and new business wins from U.S. onshoring and global OEMs. Fiscal 2025 guidance was raised, with continued focus on mitigating tariff impacts and executing restructuring in Europe.
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Catalyst Timeline.

Every result, order win, insider trade, ECS update, earnings-call, and SEC announcement for this company — in one chronological lane.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Full Report.

Read the complete Finmagine™ investment research report — comprehensive fundamental analysis, business model assessment, competitive positioning, and investment recommendation.

Upgrade to PremiumCreate Free Account

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯
Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.
📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

Financial Model
Projections are built from each company's audited annual financials (Income Statement, Balance Sheet, Cash Flow) over the last 5 fiscal years. Forward assumptions — revenue growth %, EBITDA margin, D&A (USD millions), interest expense, tax rate, and capex — are AI-generated using historical context and refreshed twice a year: after the December results season and after the September/Q4 results season.

DCF Valuation
Fair Value = Σ(FCFt / (1+WACC)t) + Terminal Value. Terminal Value uses the Gordon Growth Model: FCF5 × (1+g) / (WACC−g). Default WACC: 10% (US risk-free ~4.5%, equity risk premium ~5.5%). Default terminal growth: 3% (long-run US nominal GDP proxy).

CAGR Tracker
Expected 5-year CAGR = (DCF Fair Value / Current Price)1/5 − 1. Assumes fair value is reached in exactly 5 years — a mechanical estimate only.

Data Sources & Limitations
Financial statements sourced from public filings. Prices updated daily. Forward assumptions are AI-generated. All monetary values in USD millions. Non-US ADR companies may have currency conversion inaccuracies. Models are point-in-time and do not update intra-quarter or account for M&A, macro shocks, or extraordinary items.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including US equities and ETFs, involves inherent risks including the potential loss of principal. All investments are subject to market fluctuations, economic conditions, regulatory changes, and other factors that may affect their value. Past performance is not indicative of future results. This analysis is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This analysis does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a licensed financial advisor or an SEC-registered investment adviser before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Not SEC-Registered:
Finmagine is not registered as an investment adviser with the U.S. Securities and Exchange Commission (SEC) or any state securities authority. Nothing on this platform constitutes investment advice as defined under the Investment Advisers Act of 1940.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities discussed. Any such positions are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company or institution.

Information Sources:
The analysis is based on publicly available information including SEC filings (10-K, 10-Q), annual reports, management commentary, and publicly available financial data. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This analysis may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. Finmagine does not undertake any obligation to update such statements in the future.

Limitation of Liability:
The content is provided "as is" without any warranties, express or implied. Finmagine expressly disclaims any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.